Alterations in GABAergic Interneurons, Neuroinflammation, and Epigenetics: Potential Targets for Therapeutic Strategies in Schizophrenia. - Matrisciano F; Ajilore OA; Davis JM; Guidotti A; Grayson DR (Current neuropharmacology, 2026)